Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Towards endemicity: large-scale expansion of the NDM-1-producing Klebsiella pneumoniae ST11 lineage in Poland, 2015-16.

Baraniak A, Machulska M, Żabicka D, Literacka E, Izdebski R, Urbanowicz P, Bojarska K, Herda M, Kozińska A, Hryniewicz W, Gniadkowski M; NDM-PL Study Group .

J Antimicrob Chemother. 2019 Aug 13. pii: dkz315. doi: 10.1093/jac/dkz315. [Epub ahead of print]

PMID:
31406993
2.

Pseudomonas aeruginosa with NDM-1, DIM-1 and PME-1 β-lactamases, and RmtD3 16S rRNA methylase, encoded by new genomic islands.

Urbanowicz P, Izdebski R, Baraniak A, Żabicka D, Ziółkowski G, Hryniewicz W, Gniadkowski M.

J Antimicrob Chemother. 2019 Jun 18. pii: dkz262. doi: 10.1093/jac/dkz262. [Epub ahead of print] No abstract available.

PMID:
31211367
3.

'A new normal with chemobrain': Experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors.

Henderson FM, Cross AJ, Baraniak AR.

Health Psychol Open. 2019 Mar 5;6(1):2055102919832234. doi: 10.1177/2055102919832234. eCollection 2019 Jan-Jun.

4.

Proteus mirabilis Producing the OXA-58 Carbapenemase in Poland.

Literacka E, Izdebski R, Baraniak A, Żabicka D, Schneider A, Urbanowicz P, Herda M, Hryniewicz W, Gniadkowski M.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00106-19. doi: 10.1128/AAC.00106-19. Print 2019 May. No abstract available.

PMID:
30833423
5.

The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains.

Adamus-Białek W, Baraniak A, Wawszczak M, Głuszek S, Gad B, Wróbel K, Bator P, Majchrzak M, Parniewski P.

Mol Biol Rep. 2018 Oct;45(5):1055-1065. doi: 10.1007/s11033-018-4254-0. Epub 2018 Jul 14.

6.

VIM/IMP carbapenemase-producing Enterobacteriaceae in Poland: epidemic Enterobacter hormaechei and Klebsiella oxytoca lineages.

Izdebski R, Baraniak A, Zabicka D, Sekowska A, Gospodarek-Komkowska E, Hryniewicz W, Gniadkowski M.

J Antimicrob Chemother. 2018 Oct 1;73(10):2675-2681. doi: 10.1093/jac/dky257.

PMID:
29986025
7.

KPC-2-producing Klebsiella pneumoniae ST11 in a Children's Hospital in Poland.

Machulska M, Baraniak A, Żak I, Bojarska K, Żabicka D, Sowa-Sierant I, Hryniewicz W, Gniadkowski M.

Pol J Microbiol. 2017 Sep 27;66(3):401-404. doi: 10.5604/01.3001.0010.4884.

PMID:
29319505
8.

Enterobacteriaceae producing OXA-48-like carbapenemases in Poland, 2013-January 2017.

Izdebski R, Baraniak A, Zabicka D, Machulska M, Urbanowicz P, Fiett J, Literacka E, Bojarska K, Kozinska A, Zieniuk B, Hryniewicz W, Gniadkowski M; OXA-48-PL Study Group.

J Antimicrob Chemother. 2018 Mar 1;73(3):620-625. doi: 10.1093/jac/dkx457.

PMID:
29237086
9.

Evaluation of the Carba NP test for carbapenemase detection in Enterobacteriaceae, Pseudomonas spp. and Acinetobacter spp., and its practical use in the routine work of a national reference laboratory for susceptibility testing.

Literacka E, Herda M, Baraniak A, Żabicka D, Hryniewicz W, Skoczyńska A, Gniadkowski M.

Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2281-2287. doi: 10.1007/s10096-017-3062-0. Epub 2017 Jul 25.

10.

Multiregional dissemination of KPC-producing Klebsiella pneumoniae ST258/ST512 genotypes in Poland, 2010-14.

Baraniak A, Izdebski R, Zabicka D, Bojarska K, Górska S, Literacka E, Fiett J, Hryniewicz W, Gniadkowski M; KPC-PL2 Study Group.

J Antimicrob Chemother. 2017 Jun 1;72(6):1610-1616. doi: 10.1093/jac/dkx054.

PMID:
28333331
11.

Mobile MCR-1-associated resistance to colistin in Poland.

Izdebski R, Baraniak A, Bojarska K, Urbanowicz P, Fiett J, Pomorska-Wesołowska M, Hryniewicz W, Gniadkowski M, Żabicka D.

J Antimicrob Chemother. 2016 Aug;71(8):2331-3. doi: 10.1093/jac/dkw261. Epub 2016 Jun 20. No abstract available.

PMID:
27330064
12.
13.

KPC-Like Carbapenemase-Producing Enterobacteriaceae Colonizing Patients in Europe and Israel.

Baraniak A, Izdebski R, Fiett J, Herda M, Derde LP, Bonten MJ, Adler A, Carmeli Y, Goossens H, Hryniewicz W, Brun-Buisson C, Gniadkowski M; MOSAR WP2, WP3, and WP5 Study Groups.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1912-7. doi: 10.1128/AAC.02756-15.

14.

NDM-producing Enterobacteriaceae in Poland, 2012-14: inter-regional outbreak of Klebsiella pneumoniae ST11 and sporadic cases.

Baraniak A, Izdebski R, Fiett J, Gawryszewska I, Bojarska K, Herda M, Literacka E, Żabicka D, Tomczak H, Pewińska N, Szarata M, Ozorowski T, Milner A, Hryniewicz W, Gniadkowski M.

J Antimicrob Chemother. 2016 Jan;71(1):85-91. doi: 10.1093/jac/dkv282. Epub 2015 Sep 19.

PMID:
26386745
15.

Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins.

Izdebski R, Fiett J, Urbanowicz P, Baraniak A, Derde LP, Bonten MJ, Carmeli Y, Goossens H, Hryniewicz W, Brun-Buisson C, Brisse S, Gniadkowski M; MOSAR WP2, WP3 and WP5 Study Groups; MOSAR WP2 WP3 and WP5 Study Groups.

J Antimicrob Chemother. 2015 Dec;70(12):3230-7. doi: 10.1093/jac/dkv273. Epub 2015 Aug 27.

PMID:
26318191
16.

NDM-1- or OXA-48-producing Enterobacteriaceae colonising Polish tourists following a terrorist attack in Tunis, March 2015.

Izdebski R, Bojarska K, Baraniak A, Literacka E, Herda M, Żabicka D, Guzek A, Półgrabia M, Hryniewicz W, Gniadkowski M.

Euro Surveill. 2015 Jun 11;20(23). pii: 21150.

17.

Survey of metallo-β-lactamase-producing Enterobacteriaceae colonizing patients in European ICUs and rehabilitation units, 2008-11.

Papagiannitsis CC, Izdebski R, Baraniak A, Fiett J, Herda M, Hrabák J, Derde LP, Bonten MJ, Carmeli Y, Goossens H, Hryniewicz W, Brun-Buisson C, Gniadkowski M; MOSAR WP2, WP3 and WP5 study groups; MOSAR WP2 WP3 and WP5 study groups.

J Antimicrob Chemother. 2015 Jul;70(7):1981-8. doi: 10.1093/jac/dkv055. Epub 2015 Mar 10.

PMID:
25759034
18.

MLST reveals potentially high-risk international clones of Enterobacter cloacae.

Izdebski R, Baraniak A, Herda M, Fiett J, Bonten MJ, Carmeli Y, Goossens H, Hryniewicz W, Brun-Buisson C, Gniadkowski M; MOSAR WP2, WP3 and WP5 Study Groups.

J Antimicrob Chemother. 2015 Jan;70(1):48-56. doi: 10.1093/jac/dku359. Epub 2014 Sep 12.

PMID:
25216820
19.

Sequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia.

Guzvinec M, Izdebski R, Butic I, Jelic M, Abram M, Koscak I, Baraniak A, Hryniewicz W, Gniadkowski M, Tambic Andrasevic A.

Antimicrob Agents Chemother. 2014 Oct;58(10):6277-83. doi: 10.1128/AAC.03116-14. Epub 2014 Jul 28.

20.

A multinational study of colonization with extended spectrum β-lactamase-producing Enterobacteriaceae in healthcare personnel and family members of carrier patients hospitalized in rehabilitation centres.

Adler A, Baraniak A, Izdebski R, Fiett J, Salvia A, Samso JV, Lawrence C, Solomon J, Paul M, Lerman Y, Schwartzberg Y, Mordechai E, Rossini A, Fierro J, Lammens C, Malhotra-Kumar S, Goossens H, Hryniewicz W, Brun-Buisson C, Gniadkowski M, Carmeli Y; MOSAR team.

Clin Microbiol Infect. 2014 Aug;20(8):O516-23. doi: 10.1111/1469-0691.12560. Epub 2014 Mar 5.

21.

The first NDM metallo-β-lactamase-producing Enterobacteriaceae isolate in Poland: evolution of IncFII-type plasmids carrying the bla(NDM-1) gene.

Fiett J, Baraniak A, Izdebski R, Sitkiewicz I, Żabicka D, Meler A, Filczak K, Hryniewicz W, Gniadkowski M.

Antimicrob Agents Chemother. 2014;58(2):1203-7. doi: 10.1128/AAC.01197-13. Epub 2013 Nov 18.

22.

Comparative population analysis of Klebsiella pneumoniae strains with extended-spectrum β-lactamases colonizing patients in rehabilitation centers in four countries.

Baraniak A, Izdebski R, Fiett J, Sadowy E, Adler A, Kazma M, Salomon J, Lawrence C, Rossini A, Salvia A, Vidal Samso J, Fierro J, Paul M, Lerman Y, Malhotra-Kumar S, Lammens C, Goossens H, Hryniewicz W, Brun-Buisson C, Carmeli Y, Gniadkowski M; MOSAR WP2 and WP5 Study Groups.

Antimicrob Agents Chemother. 2013 Apr;57(4):1992-7. doi: 10.1128/AAC.02571-12. Epub 2013 Feb 12.

23.

A binational cohort study of intestinal colonization with extended-spectrum β-lactamase-producing Proteus mirabilis in patients admitted to rehabilitation centres.

Adler A, Baraniak A, Izdebski R, Fiett J, Gniadkowski M, Hryniewicz W, Salvia A, Rossini A, Goossens H, Malhotra S, Lerman Y, Elenbogen M, Carmeli Y; MOSAR WP5 & WP2 study groups.

Clin Microbiol Infect. 2013 Feb;19(2):E51-8. doi: 10.1111/1469-0691.12072. Epub 2012 Dec 4.

24.

Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries.

Izdebski R, Baraniak A, Fiett J, Adler A, Kazma M, Salomon J, Lawrence C, Rossini A, Salvia A, Vidal Samso J, Fierro J, Paul M, Lerman Y, Malhotra-Kumar S, Lammens C, Goossens H, Hryniewicz W, Brun-Buisson C, Carmeli Y, Gniadkowski M; MOSAR WP2 and WP5 Study Groups.

Antimicrob Agents Chemother. 2013 Jan;57(1):309-16. doi: 10.1128/AAC.01656-12. Epub 2012 Oct 31.

25.

Characterization of two new CTX-M-25-group extended-spectrum β-lactamase variants identified in Escherichia coli isolates from Israel.

Vervoort J, Baraniak A, Gazin M, Sabirova J, Lammens C, Kazma M, Grabowska A, Izdebski R, Carmeli Y, Kumar-Singh S, Gniadkowski M, Goossens H, Malhotra-Kumar S; MOSAR WP2; SATURN WP1 study groups.

PLoS One. 2012;7(9):e46329. doi: 10.1371/journal.pone.0046329. Epub 2012 Sep 26.

26.

Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre.

Adler A, Gniadkowski M, Baraniak A, Izdebski R, Fiett J, Hryniewicz W, Malhotra-Kumar S, Goossens H, Lammens C, Lerman Y, Kazma M, Kotlovsky T, Carmeli Y; MOSAR WP5 and WP2 study groups.

Clin Microbiol Infect. 2012 Dec;18(12):E497-505. doi: 10.1111/j.1469-0691.2012.03999.x. Epub 2012 Sep 11.

27.

Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009.

Baraniak A, Grabowska A, Izdebski R, Fiett J, Herda M, Bojarska K, Żabicka D, Kania-Pudło M, Młynarczyk G, Żak-Puławska Z, Hryniewicz W, Gniadkowski M; KPC-PL Study Group.

Antimicrob Agents Chemother. 2011 Dec;55(12):5493-9. doi: 10.1128/AAC.05118-11. Epub 2011 Sep 19.

28.

Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe.

D'Andrea MM, Literacka E, Zioga A, Giani T, Baraniak A, Fiett J, Sadowy E, Tassios PT, Rossolini GM, Gniadkowski M, Miriagou V.

Antimicrob Agents Chemother. 2011 Jun;55(6):2735-42. doi: 10.1128/AAC.01736-10. Epub 2011 Mar 14.

29.

The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: a systematic review and meta-analysis.

Baraniak A, Sheffield D.

Patient Educ Couns. 2011 Apr;83(1):29-36. doi: 10.1016/j.pec.2010.04.010. Epub 2010 May 5. Review.

PMID:
20447795
30.

Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.

Baraniak A, Izdebski R, Herda M, Fiett J, Hryniewicz W, Gniadkowski M, Kern-Zdanowicz I, Filczak K, Łopaciuk U.

Antimicrob Agents Chemother. 2009 Oct;53(10):4565-7. doi: 10.1128/AAC.00436-09. Epub 2009 Jul 20. No abstract available.

31.

blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.

Literacka E, Bedenic B, Baraniak A, Fiett J, Tonkic M, Jajic-Bencic I, Gniadkowski M.

Antimicrob Agents Chemother. 2009 Apr;53(4):1630-5. doi: 10.1128/AAC.01431-08. Epub 2009 Feb 2.

32.

Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.

Empel J, Baraniak A, Literacka E, Mrówka A, Fiett J, Sadowy E, Hryniewicz W, Gniadkowski M; Beta-PL Study Group.

Antimicrob Agents Chemother. 2008 Jul;52(7):2449-54. doi: 10.1128/AAC.00043-08. Epub 2008 May 5.

33.

Complete nucleotide sequence of the pCTX-M3 plasmid and its involvement in spread of the extended-spectrum beta-lactamase gene blaCTX-M-3.

Gołebiewski M, Kern-Zdanowicz I, Zienkiewicz M, Adamczyk M, Zylinska J, Baraniak A, Gniadkowski M, Bardowski J, Cegłowski P.

Antimicrob Agents Chemother. 2007 Nov;51(11):3789-95. Epub 2007 Aug 13.

34.
35.

Molecular epidemiology of acquired-metallo-beta-lactamase-producing bacteria in Poland.

Fiett J, Baraniak A, Mrówka A, Fleischer M, Drulis-Kawa Z, Naumiuk Ł, Samet A, Hryniewicz W, Gniadkowski M.

Antimicrob Agents Chemother. 2006 Mar;50(3):880-6.

36.

High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients.

Goethaert K, Van Looveren M, Lammens C, Jansens H, Baraniak A, Gniadkowski M, Van Herck K, Jorens PG, Demey HE, Ieven M, Bossaert L, Goossens H.

Clin Microbiol Infect. 2006 Jan;12(1):56-62.

37.

Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice.

Baraniak AP, Chen JR, Garcia-Blanco MA.

Mol Cell Biol. 2006 Feb;26(4):1209-22.

38.

Evolution of TEM-type extended-spectrum beta-lactamases in clinical Enterobacteriaceae strains in Poland.

Baraniak A, Fiett J, Mrówka A, Walory J, Hryniewicz W, Gniadkowski M.

Antimicrob Agents Chemother. 2005 May;49(5):1872-80.

39.

Characterization of the intronic splicing silencers flanking FGFR2 exon IIIb.

Wagner EJ, Baraniak AP, Sessions OM, Mauger D, Moskowitz E, Garcia-Blanco MA.

J Biol Chem. 2005 Apr 8;280(14):14017-27. Epub 2005 Jan 31.

40.

Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland.

Literacka E, Empel J, Baraniak A, Sadowy E, Hryniewicz W, Gniadkowski M.

Antimicrob Agents Chemother. 2004 Nov;48(11):4136-43.

41.

Multiple outbreaks of nosocomial salmonellosis in Russia and Belarus caused by a single clone of Salmonella enterica serovar Typhimurium producing an extended-spectrum beta-lactamase.

Edelstein M, Pimkin M, Dmitrachenko T, Semenov V, Kozlova N, Gladin D, Baraniak A, Stratchounski L.

Antimicrob Agents Chemother. 2004 Aug;48(8):2808-15.

42.

Molecular epidemiology of Serratia marcescens in two hospitals in Gdańsk, Poland, over a 5-year period.

Naumiuk L, Baraniak A, Gniadkowski M, Krawczyk B, Rybak B, Sadowy E, Samet A, Kur J.

J Clin Microbiol. 2004 Jul;42(7):3108-16. Erratum in: J Clin Microbiol. 2004 Aug;42(8):3914.

43.

Alternative splicing in disease and therapy.

Garcia-Blanco MA, Baraniak AP, Lasda EL.

Nat Biotechnol. 2004 May;22(5):535-46.

PMID:
15122293
44.
45.

Complex endemic situation regarding extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a hospital in Slovenia.

Jutersek B, Baraniak A, Zohar-Cretnik T, Storman A, Sadowy E, Gniadkowski M.

Microb Drug Resist. 2003;9 Suppl 1:S25-33.

PMID:
14633364
46.

Quantification of alternatively spliced FGFR2 RNAs using the RNA invasive cleavage assay.

Wagner EJ, Curtis ML, Robson ND, Baraniak AP, Eis PS, Garcia-Blanco MA.

RNA. 2003 Dec;9(12):1552-61.

47.

Evaluation and comparison of random amplification of polymorphic DNA, pulsed-field gel electrophoresis and ADSRRS-fingerprinting for typing Serratia marcescens outbreaks.

Krawczyk B, Naumiuk L, Lewandowski K, Baraniak A, Gniadkowski M, Samet A, Kur J.

FEMS Immunol Med Microbiol. 2003 Oct 15;38(3):241-8.

48.

Evaluation of the BD Phoenix automated identification and susceptibility testing system in clinical microbiology laboratory practice.

Stefaniuk E, Baraniak A, Gniadkowski M, Hryniewicz W.

Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):479-85. Epub 2003 Jul 18.

PMID:
12884060
49.

[Usefulness of soluble ICAM-1 measurements for the evaluation of the disease activity and efficiency of therapy in patients with infiltrative Graves' ophthalmopathy].

Kulig G, Pilarska K, Kulig J, Krzyzanowska-Swiniarska B, Robaczyk M, Baraniak A.

Pol Arch Med Wewn. 2002 Dec;108(6):1161-9. Polish.

PMID:
12687928
50.

Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland.

Baraniak A, Fiett J, Hryniewicz W, Nordmann P, Gniadkowski M.

J Antimicrob Chemother. 2002 Sep;50(3):393-6.

PMID:
12205064

Supplemental Content

Loading ...
Support Center